Orbit Biotech

orbitbiotech.com

Estd in 2006, Orbit Biotech is a flagship biotech division of Zodiac Brand Space Pvt. Ltd. an ISO 9001:2008 certified company. The company is focussed on its research in Probiotics and the team has successfully completed many research projects funded by Department of Biotechnology (DBT), Govt. of India. Several in-house research projects aiming at developing state of the art probiotic applications are under process. The company is pioneer in training biotech students and professionals aiming at creating a skilled biotech professionals though its programs. Our aspiration is to provide biotechnology solutions by finding better methods of applications and work actively to promote collaborations between all parties in biotechnological industry in order to achieve our common goal of global competence. Our research and technology leads to the discovery of new and innovative products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

THERMO FISHER SCIENTIFIC’S LARGEST SINGLE-USE TECHNOLOGY MANUFACTURING SITE OPENS IN GREATER NASHVILLE

Thermo Fisher Scientific Inc. | August 23, 2022

news image

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-square-foot facility enables the company to help meet rapidly growing demand for the bioprocessing materials needed to produce vaccines and breakthrough therapies for cancer and other diseases. This new site is part of Thermo Fisher’s $650 million multi-year investment to expand its bioprocessing production cap...

Read More

STEM CELL MODELS OF HUMAN SPINE DEVELOPMENT UNVEILED

Drug Target Review | January 15, 2020

news image

Scientists have created the first lab-dish models of the cellular clock, where each ‘tick’ stimulates the formation of the vertebra, which uses stem cells derived from adult human tissue. Over 20 years ago, Olivier Pourquié’s lab at Harvard University, US discovered a cellular clock in chicken embryos where each ‘tick’ stimulates the formation of a structure called a somite that ultimately becomes a vertebra. Now, Pourquié has led one of two teams to c...

Read More

MEDTECH

AMPEL BIOSOLUTIONS' PRECISION MEDICINE BREAKTHROUGH PREDICTS DRUG OPTIONS WITH RNA ANALYTICS & MACHINE LEARNING

AMPEL BioSolutions | July 07, 2022

news image

AMPEL BioSolutions announces a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer. Revealed at the Precision Medicine World Conference in Silicon Valley California, the first-in-class platform technology utilizes RNA analytics and machine learning to characterize an individual's gene expression and provide clinical decision support to physicians for tre...

Read More

ARBOR VITA LAUNCHES OPEN PLATFORM COVID-19 ANTIBODY TEST EXPANDING ACCESS TO HIGHER QUALITY DIAGNOSTICS

Arbor Vita | June 08, 2020

news image

Arbor Vita announced today the availability of its CoVisa™ IgG ELISA-based test for antibodies associated with the novel coronavirus (COVID-19). The test has been found to have a 100 percent sensitivity (positive percentage agreement), and 99.24 percent specificity (negative percentage). Additional validation testing is ongoing in independent laboratories. The company has notified the U.S. Food and Drug Administration under the Emergency Use Authorization (EUA) process.Arbor Vita'...

Read More
news image

INDUSTRIAL IMPACT

THERMO FISHER SCIENTIFIC’S LARGEST SINGLE-USE TECHNOLOGY MANUFACTURING SITE OPENS IN GREATER NASHVILLE

Thermo Fisher Scientific Inc. | August 23, 2022

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-square-foot facility enables the company to help meet rapidly growing demand for the bioprocessing materials needed to produce vaccines and breakthrough therapies for cancer and other diseases. This new site is part of Thermo Fisher’s $650 million multi-year investment to expand its bioprocessing production cap...

Read More
news image

STEM CELL MODELS OF HUMAN SPINE DEVELOPMENT UNVEILED

Drug Target Review | January 15, 2020

Scientists have created the first lab-dish models of the cellular clock, where each ‘tick’ stimulates the formation of the vertebra, which uses stem cells derived from adult human tissue. Over 20 years ago, Olivier Pourquié’s lab at Harvard University, US discovered a cellular clock in chicken embryos where each ‘tick’ stimulates the formation of a structure called a somite that ultimately becomes a vertebra. Now, Pourquié has led one of two teams to c...

Read More
news image

MEDTECH

AMPEL BIOSOLUTIONS' PRECISION MEDICINE BREAKTHROUGH PREDICTS DRUG OPTIONS WITH RNA ANALYTICS & MACHINE LEARNING

AMPEL BioSolutions | July 07, 2022

AMPEL BioSolutions announces a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer. Revealed at the Precision Medicine World Conference in Silicon Valley California, the first-in-class platform technology utilizes RNA analytics and machine learning to characterize an individual's gene expression and provide clinical decision support to physicians for tre...

Read More
news image

ARBOR VITA LAUNCHES OPEN PLATFORM COVID-19 ANTIBODY TEST EXPANDING ACCESS TO HIGHER QUALITY DIAGNOSTICS

Arbor Vita | June 08, 2020

Arbor Vita announced today the availability of its CoVisa™ IgG ELISA-based test for antibodies associated with the novel coronavirus (COVID-19). The test has been found to have a 100 percent sensitivity (positive percentage agreement), and 99.24 percent specificity (negative percentage). Additional validation testing is ongoing in independent laboratories. The company has notified the U.S. Food and Drug Administration under the Emergency Use Authorization (EUA) process.Arbor Vita'...

Read More